{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:19:31Z","timestamp":1769102371652,"version":"3.49.0"},"reference-count":151,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.clinbiochem.2012.12.005","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T13:31:01Z","timestamp":1355405461000},"page":"566-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Biochemical pathogenesis of aspirin exacerbated respiratory disease (AERD)"],"prefix":"10.1016","volume":"46","author":[{"given":"Arun","family":"Narayanankutty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Manuel","family":"Res\u00e9ndiz-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramc\u00e9s","family":"Falf\u00e1n-Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis M.","family":"Teran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0005","first-page":"189","article-title":"Anaphylaxie et idiosyncrasie","volume":"30","author":"Widal","year":"1922","journal-title":"Presse Med"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0021-8707(67)90076-7","article-title":"Concerning the nature of intolerance to aspirin","volume":"40","author":"Samter","year":"1967","journal-title":"J Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0015","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","article-title":"Intolerance to aspirin. Clinical studies and consideration of its pathogenesis","volume":"68","author":"Samter","year":"1968","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0020","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat New Biol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/bmj.1.5949.67","article-title":"Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients","volume":"1","author":"Szczeklik","year":"1975","journal-title":"Br Med J"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0030","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1034\/j.1399-3003.1999.14c21.x","article-title":"Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis","volume":"14","author":"Varga","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0035","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2005.08.035","article-title":"Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma","volume":"116","author":"Mascia","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0040","first-page":"173","article-title":"Clinical factors influencing the eosinophil infiltration of nasal polyps","volume":"40","author":"Jankowski","year":"2002","journal-title":"Rhinology"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0045","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1398-9995.2001.00913.x","article-title":"Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma","volume":"56","author":"Mita","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0050","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.rmed.2008.03.017","article-title":"Association of three sets of high-affinity IgE receptor (FcepsilonR1) polymorphisms with aspirin-intolerant asthma","volume":"102","author":"Palikhe","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0055","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1365-2222.2006.02443.x","article-title":"A polymorphism of MS4A2 (\u2212109T>C) encoding the beta-chain of the high-affinity immunoglobulin E receptor (FcepsilonR1beta) is associated with a susceptibility to aspirin-intolerant asthma","volume":"36","author":"Kim","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2500\/aap.2006.27.2908","article-title":"Role of staphylococcal superantigen-specific IgE antibodies in aspirin-intolerant asthma","volume":"27","author":"Lee","year":"2006","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clim.2008.09.008","article-title":"Aspirin and salicylates modulate IgE-mediated leukotriene secretion in mast cells through a dihydropyridine receptor-mediated Ca(2+) influx","volume":"131","author":"Togo","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0070","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev-physiol-021909-135926","article-title":"TH17 cells in asthma and COPD","volume":"72","author":"Alcorn","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0075","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.micinf.2009.04.003","article-title":"IL-17 and Th17 cells in human inflammatory diseases","volume":"5","author":"Miossec","year":"2009","journal-title":"Microbes Infect"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0080","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/ajrccm.156.5.9702072","article-title":"Expression of interleukin-5 and granulocyte-macrophage colony-stimulating factor in aspirin-sensitive and non-aspirin-sensitive asthmatic airways","volume":"156","author":"Sousa","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0085","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2500\/ajr.2007.21.3066","article-title":"Exhaled inflammatory markers in aspirin-induced asthma syndrome","volume":"21","author":"Carpagnano","year":"2007","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0090","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.rmed.2010.04.017","article-title":"Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge","volume":"104","author":"Kupczyk","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0095","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1398-9995.2005.00753.x","article-title":"Association of stem cell factor expression in nasal polyp epithelial cells with aspirin sensitivity and asthma","volume":"60","author":"Kowalski","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0100","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2500\/aap.2007.28.3052","article-title":"Cytokine expression in peripheral blood lymphocytes before and after aspirin desensitization in aspirin-exacerbated respiratory disease","volume":"28","author":"Shome","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0105","first-page":"182090","article-title":"Interleukin-4 in the generation of the AERD phenotype: implications for molecular mechanisms driving therapeutic benefit of aspirin desensitization","author":"Steinke","year":"2012","journal-title":"J Allergy (Cairo) 2012"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0110","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1365-2222.2006.02567.x","article-title":"Association of TNF-alpha genetic polymorphism with HLA DPB1*0301","volume":"36","author":"Kim","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0115","first-page":"741313","article-title":"The IL1B-511 polymorphism (rs16944 AA genotype) is increased in aspirin-exacerbated respiratory disease in Mexican population","author":"Falf\u00e1n-Valencia","year":"2012","journal-title":"J Allergy (Cairo) 2012"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0120","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/FPC.0b013e3283402155","article-title":"Effect of single nucleotide polymorphisms within the interleukin-4 promoter on aspirin intolerance in asthmatics and interleukin-4 promoter activity","volume":"20","author":"Kim","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0125","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.anai.2011.09.003","article-title":"IL-13 and IL-17A gene polymorphisms in Japanese patients with aspirin-exacerbated respiratory disease","volume":"107","author":"Kohyama","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0130","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.rmed.2006.07.002","article-title":"Association between a TGFbeta1 promoter polymorphism and rhinosinusitis in aspirin-intolerant asthmatic patients","volume":"101","author":"Kim","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0135","doi-asserted-by":"crossref","first-page":"498S","DOI":"10.1093\/ajcn\/87.2.498S","article-title":"Mechanisms by which botanical lipids affect inflammatory disorders","volume":"87","author":"Chilton","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0140","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.plipres.2006.05.003","article-title":"Properties of the Group IV phospholipase A2 family","volume":"45","author":"Ghosh","year":"2006","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0145","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.biochem.76.062405.154007","article-title":"Biochemistry and physiology of mammalian secreted phospholipases A2","volume":"77","author":"Lambeau","year":"2008","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0150","doi-asserted-by":"crossref","first-page":"16709","DOI":"10.1074\/jbc.272.27.16709","article-title":"Properties and regulation of cytosolic phospholipase A2","volume":"272","author":"Leslie","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0155","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1124\/pr.58.3.8","article-title":"Eicosanoid transcellular biosynthesis: from cell\u2013cell interactions to in vivo tissue responses","volume":"58","author":"Folco","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0165","doi-asserted-by":"crossref","first-page":"33157","DOI":"10.1074\/jbc.271.52.33157","article-title":"Prostaglandin endoperoxide H synthases(cyclooxygenases)-1 and -2","volume":"271","author":"Smith","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0170","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.1073\/pnas.162468699","article-title":"COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure, and expression","volume":"99","author":"Chandrasekharan","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0175","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/thx.2007.080903","article-title":"Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity","volume":"63","author":"Mastalerz","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0185","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1164\/ajrccm\/137.4.847","article-title":"Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin","volume":"137","author":"Ferreri","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1164\/ajrccm.160.1.9808048","article-title":"Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics","volume":"160","author":"Picado","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0195","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000329744","article-title":"Expression of arachidonate metabolism enzymes and receptors in nasal polyps of aspirin-hypersensitive asthmatics","volume":"157","author":"Adamusiak","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0200","first-page":"207","article-title":"Deficiency of cyclooxygenases transcripts in cultured primary bronchial epithelial cells of aspirin-sensitive asthmatics","volume":"58","author":"Pierzchalska","year":"2007","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1183\/09031936.05.00140104","article-title":"Cyclooxygenase-1 gene polymorphisms in patients with different asthma phenotypes and atopy","volume":"26","author":"Shi","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0210","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000205584","article-title":"Aspirin-induced COX-2 overexpression in monocytes of aspirin-intolerant patients","volume":"149","author":"Morgan","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0215","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2011.01.065","article-title":"Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma","volume":"128","author":"Roca-Ferrer","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0220","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1067\/mai.2003.1450","article-title":"Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib","volume":"111","author":"Gyllfors","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0225","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2500\/aap.2011.32.3413","article-title":"Selective cyclooxygenase-2 inhibitor cross-reactivity in aspirin-exacerbated respiratory disease","volume":"32","author":"Umemoto","year":"2011","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0230","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.it.2003.11.001","article-title":"The lung as a privileged site for the beneficial actions of PGE2","volume":"25","author":"Vancheri","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0235","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1172\/JCI38369","article-title":"The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice","volume":"120","author":"Bauman","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0240","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1128\/MCB.01776-08","article-title":"Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis","volume":"29","author":"Coward","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0245","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clim.2006.01.016","article-title":"Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases","volume":"119","author":"Park","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0250","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0090-6980(02)00043-6","article-title":"Prostaglandin E synthase","volume":"68\u201369","author":"Murakami","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0255","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/pr.110.003517","article-title":"International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15years of progress","volume":"63","author":"Woodward","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0260","unstructured":"http:\/\/www.iuphar-db.org\/DATABASE\/FamilyMenuForward?familyId=58"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0265","first-page":"675","article-title":"Pharmacologic and therapeutic implications of prostaglandins on airway smooth muscle","volume":"17","author":"Wasserman","year":"1981","journal-title":"Bull Eur Physiopathol Respir"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0270","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1164\/ajrccm.153.2.8564099","article-title":"Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma","volume":"153","author":"Szczeklik","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0275","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/ajrccm.153.2.8564100","article-title":"Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma","volume":"153","author":"Sestini","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0280","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1046\/j.1365-2222.2001.01074.x","article-title":"Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E(2) on this release from peripheral blood leucocytes in aspirin-induced asthmatic patients","volume":"31","author":"Celik","year":"2001","journal-title":"Clin Exp Allergy"},{"issue":"Suppl.","key":"10.1016\/j.clinbiochem.2012.12.005_bb0285","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1194\/jlr.R800062-JLR200","article-title":"5-Lipoxygenase: mechanisms of regulation","volume":"50","author":"R\u00e5dmark","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0290","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1164\/rccm.200311-1595OC","article-title":"Higher prostaglandin e2 production by dendritic cells from subjects with asthma compared with normal subjects","volume":"170","author":"Long","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0295","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1164\/ajrccm.149.4.8143059","article-title":"Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge","volume":"149","author":"Sladek","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0300","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2222.2009.03386.x","article-title":"Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum: association with asthma severity and eosinophilic inflammation","volume":"40","author":"Aggarwal","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0305","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.jaci.2006.01.049","article-title":"Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13","volume":"117","author":"Trudeau","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0310","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jaci.2005.10.037","article-title":"Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells","volume":"117","author":"Ying","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0315","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1093\/hmg\/ddh332","article-title":"Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach","volume":"13","author":"Jinnai","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0320","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.fpc.0000239977.61841.fe","article-title":"Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma","volume":"17","author":"Kim","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0325","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0167-4838(00)00161-8","article-title":"Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase","volume":"1482","author":"Urade","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0330","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0952-3278(03)00077-2","article-title":"Hematopoietic prostaglandin D synthase","volume":"69","author":"Kanaoka","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0335","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2332\/allergolint.08-RAI-0033","article-title":"Role of prostaglandin D(2) and its receptors in the pathophysiology of asthma","volume":"57","author":"Oguma","year":"2008","journal-title":"Allergol Int"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0340","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0014-5793(99)01551-3","article-title":"cDNA cloning, expression and characterization of human prostaglandin F synthase","volume":"462","author":"Suzuki-Yamamoto","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0345","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1021\/bi036046x","article-title":"Crystal structure of human prostaglandin F synthase (AKR1C3)","volume":"43","author":"Komoto","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0350","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1432-1033.1992.tb16952.x","article-title":"Purification and properties of prostaglandin 9-ketoreductase from pig and human kidney. Identity with human carbonyl reductase","volume":"206","author":"Schieber","year":"1992","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0355","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/med.20098","article-title":"Novel cyclooxygenase-catalyzed bioactive prostaglandin F2alpha from physiology to new principles in inflammation","volume":"27","author":"Basu","year":"2007","journal-title":"Med Res Rev"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0360","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jmb.2006.09.039","article-title":"Crystal structure of the human prostacyclin synthase","volume":"364","author":"Chiang","year":"2006","journal-title":"J Mol Biol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0365","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0021-9258(17)31235-8","article-title":"On the mechanism of prostacyclin and thromboxane A2 biosynthesis","volume":"264","author":"Hecker","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0370","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2217\/pgs.10.181","article-title":"Association analysis of thromboxane A synthase 1 gene polymorphisms with aspirin intolerance in asthmatic patients","volume":"12","author":"Oh","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0375","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2222.2005.02220.x","article-title":"Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma","volume":"35","author":"Kim","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0380","first-page":"477","article-title":"Thromboxane A2 receptor +795T>C and chemoattractant receptor-homologous molecule expressed on Th2 cells -466T>C gene polymorphisms in patients with aspirin-exacerbated respiratory disease","volume":"5","author":"Kohyama","year":"2012","journal-title":"Mol Med Report"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0385","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1046\/j.1365-2745.2002.01507.x","article-title":"A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma","volume":"32","author":"Higashi","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0390","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1067\/mai.2003.1387","article-title":"A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge","volume":"111","author":"Bochenek","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0395","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jaci.2009.12.977","article-title":"Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers","volume":"125","author":"Higashi","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0400","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1074\/jbc.M706839200","article-title":"Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans","volume":"283","author":"Song","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0405","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jaci.2011.09.019","article-title":"Urinary tetranor-PGDM concentrations in aspirin-intolerant asthma and anaphylaxis","volume":"129","author":"Higashi","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0410","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1398-9995.2009.02158.x","article-title":"Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease","volume":"65","author":"Palikhe","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0415","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2217\/14622416.10.3.375","article-title":"Association of CRTH2 gene polymorphisms with the required dose of antihistamines in patients with chronic urticaria","volume":"10","author":"Palikhe","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0420","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1042\/BJ20070289","article-title":"Biosynthesis and metabolism of leukotrienes","volume":"405","author":"Murphy","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0425","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1172\/JCI620","article-title":"Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma","volume":"101","author":"Cowburn","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0430","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/path.1979","article-title":"Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma","volume":"209","author":"Adamjee","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0435","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00439-004-1082-1","article-title":"Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase","volume":"114","author":"Choi","year":"2004","journal-title":"Hum Genet"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0440","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1398-9995.2005.00780.x","article-title":"Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness","volume":"60","author":"Kim","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0445","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1073\/pnas.94.12.6148","article-title":"Discovery of a second 15S-lipoxygenase in humans","volume":"94","author":"Brash","year":"1997","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0450","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1073\/pnas.87.15.5638","article-title":"Molecular cloning, primary structure, and expression of the human platelet\/erythroleukemia cell 12-lipoxygenase","volume":"87","author":"Funk","year":"1990","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0455","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1182\/blood.V91.1.64","article-title":"Membrane translocation of 15-lipoxygenase in hematopoietic cells is calcium-dependent and activates the oxygenase activity of the enzyme","volume":"91","author":"Brinckmann","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0460","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0090-6980(94)00005-H","article-title":"12-Lipoxygenase in Lewis lung carcinoma cells: molecular identity, intracellular distribution of activity and protein, and Ca(2+)-dependent translocation from cytosol to membranes","volume":"49","author":"Hagmann","year":"1995","journal-title":"Prostaglandins"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0465","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000335681","article-title":"Effect of genetic polymorphism of ALOX15 on aspirin-exacerbated respiratory disease","volume":"159","author":"Song","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0470","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0475","doi-asserted-by":"crossref","first-page":"13923","DOI":"10.1074\/jbc.272.21.13923","article-title":"Site-directed mutagenesis of human leukotriene C4 synthase","volume":"272","author":"Lam","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0480","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/pr.110.004184","article-title":"International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions","volume":"63","author":"B\u00e4ck","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0485","unstructured":"http:\/\/www.iuphar-db.org\/DATABASE\/FamilyMenuForward?familyId=35"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0490","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1164\/rccm.2101021","article-title":"Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma","volume":"166","author":"Antczak","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0495","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/thx.2008.101196","article-title":"Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma","volume":"63","author":"Gaber","year":"2008","journal-title":"Thorax"},{"issue":"1\u20133","key":"10.1016\/j.clinbiochem.2012.12.005_bb0500","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejphar.2006.05.044","article-title":"Aspirin induces the production of the inflammatory mediator 8-epi-PGF in mast cells","volume":"543","author":"Mortaz","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0505","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/ajrccm\/140.1.148","article-title":"Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma","volume":"140","author":"Arm","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0510","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaci.2003.10.068","article-title":"Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): involvement of chronic hyperplastic rhinosinusitis with nasal polyposis","volume":"113","author":"Higashi","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0515","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","article-title":"Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects","volume":"143","author":"Christie","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0520","first-page":"48","article-title":"Increased excretion of leukotriene E4 during aspirin-induced asthma","volume":"119","author":"Knapp","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0525","first-page":"20","article-title":"Dal Negro RW. Aspirin induced asthma (AIA) with nasal polyps has the highest basal LTE4 excretion: a study vs AIA without polyps, mild topic asthma, and normal controls","volume":"38","author":"Micheletto","year":"2006","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0530","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1165\/rcmb.2002-0174OC","article-title":"Bronchial mast cells are the dominating LTC4S-expressing cells in aspirin-tolerant asthma","volume":"29","author":"Cai","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0535","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1067\/mai.2003.67","article-title":"Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma","volume":"111","author":"Steinke","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0540","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1081-1206(10)62265-X","article-title":"LTC4-synthase A-444C polymorphism: lack of association with NSAID-induced isolated periorbital angioedema in a Spanish population","volume":"87","author":"Torres-Galv\u00e1n","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0545","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0140-6736(05)64015-9","article-title":"Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma","volume":"350","author":"Sanak","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0550","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1067\/mai.2002.124466","article-title":"Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma","volume":"109","author":"Kawagishi","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0555","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1067\/mai.2000.107603","article-title":"5\u2032 flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States","volume":"106","author":"Van Sambeek","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0560","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaci.2004.02.008","article-title":"Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma","volume":"113","author":"Kedda","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0565","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1046\/j.1365-2222.2002.01531.x","article-title":"Uncoupled regulation of leukotriene C4 synthase in platelets from aspirin-intolerant asthmatics and healthy volunteers after aspirin treatment","volume":"32","author":"Tornhamre","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0570","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1365-2222.2011.03720.x","article-title":"Over-expression of the LTC4 synthase gene in mice reproduces human aspirin-induced asthma","volume":"41","author":"Hirata","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0575","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa013508","article-title":"Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis","volume":"347","author":"Sousa","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0580","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000099228","article-title":"Cysteinyl leukotriene receptor expression in aspirin-sensitive nasal polyposis patients","volume":"69","author":"Ozen","year":"2007","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0585","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2222.2006.02457.x","article-title":"Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males","volume":"36","author":"Kim","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0590","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/01.fpc.0000166456.84905.a0","article-title":"Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics","volume":"15","author":"Park","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0595","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0600","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1100\/tsw.2007.186","article-title":"Lipoxin receptors","volume":"7","author":"Romano","year":"2007","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0605","first-page":"2144","article-title":"Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis","volume":"34","author":"Hashimoto","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0610","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.plefa.2005.05.010","article-title":"Lipoxins and lipoxin analogs in asthma","volume":"73","author":"Levy","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0615","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ni1056","article-title":"Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway","volume":"5","author":"Karp","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0620","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/j.1398-9995.2009.02047.x","article-title":"Lipoxin A4 generation is decreased in aspirin-sensitive patients in lysine-aspirin nasal challenge in vivo model","volume":"64","author":"Kupczyk","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0625","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1365-2222.2007.02806.x","article-title":"Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity","volume":"37","author":"Celik","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0630","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.1365-2222.2011.03839.x","article-title":"Urinary concentrations of 15-epimer of lipoxin A(4) are lower in patients with aspirin-intolerant compared with aspirin-tolerant asthma","volume":"41","author":"Yamaguchi","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0640","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1034\/j.1399-3003.2000.16a08.x","article-title":"Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics","volume":"16","author":"Sanak","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0645","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/jhg.2012.12","article-title":"Association analysis of formyl peptide receptor 2 (FPR2) polymorphisms and aspirin exacerbated respiratory diseases","volume":"57","author":"Kim","year":"2012","journal-title":"J Hum Genet"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0650","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1073\/pnas.0710127105","article-title":"Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells","volume":"105","author":"Feltenmark","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0655","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.prostaglandins.2008.12.003","article-title":"On the biosynthesis and biological role of eoxins and 15-lipoxygenase-1 in airway inflammation and Hodgkin lymphoma","volume":"89","author":"Claesson","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0660","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1365-2222.2009.03261.x","article-title":"Concentration of 14,15-leukotriene C4 (eoxin C4) in bronchoalveolar lavage fluid","volume":"39","author":"Ono","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0665","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jaci.2010.07.015","article-title":"Eoxins: a new inflammatory pathway in childhood asthma","volume":"126","author":"Sachs-Olsen","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0670","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1476-5381.2009.00168.x","article-title":"The hepoxilins and some analogues: a review of their biology","volume":"158","author":"Pace-Asciak","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0675","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1111\/j.1742-4658.2007.05910.x","article-title":"Roux-Van der Merwe R. Structure, biochemistry and biology of hepoxilins: an update","volume":"274","author":"Nigam","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0680","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1073\/pnas.0400832101","article-title":"Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia","volume":"101","author":"Mrsny","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0685","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.2001.280.1.H1","article-title":"The lung HETEs (and EETs) up","volume":"280","author":"Jacobs","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"Suppl.","key":"10.1016\/j.clinbiochem.2012.12.005_bb0690","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1194\/jlr.R800038-JLR200","article-title":"Arachidonic acid cytochrome P450 epoxygenase pathway","volume":"50","author":"Spector","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0695","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0700","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1378\/chest.07-0371","article-title":"Promoter polymorphism G-50T of a human CYP2J2 epoxygenase gene is associated with common susceptibility to asthma","volume":"132","author":"Polonikov","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0705","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1097\/00006123-200012000-00029","article-title":"16(R)-hydroxyeicosatetraenoic acid, a novel cytochrome P450 product of arachidonic acid, suppresses activation of human polymorphonuclear leukocyte and reduces intracranial pressure in a rabbit model of thromboembolic stroke","volume":"47","author":"Bednar","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0710","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000322077","article-title":"CYP2C19 gene polymorphism may be a risk factor for bronchial asthma","volume":"20","author":"Yildirim Yaro\u011flu","year":"2011","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0715","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jaci.2011.07.013","article-title":"Polymorphisms of the CYP2C19 gene in Japanese patients with aspirin-exacerbated respiratory disease","volume":"128","author":"Kohyama","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0720","doi-asserted-by":"crossref","first-page":"15533","DOI":"10.1074\/jbc.R700047200","article-title":"Human biochemistry of the isoprostane pathway","volume":"283","author":"Milne","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0725","doi-asserted-by":"crossref","first-page":"L1067","DOI":"10.1152\/ajplung.2001.280.6.L1067","article-title":"Isoprostanes: an overview and putative roles in pulmonary pathophysiology","volume":"280","author":"Janssen","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0730","doi-asserted-by":"crossref","first-page":"27147","DOI":"10.1074\/jbc.272.43.27147","article-title":"Functional characterization of the ocular prostaglandin f2alpha (PGF2alpha) receptor. Activation by the isoprostane, 12-iso-PGF2alpha","volume":"272","author":"Kunapuli","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0735","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI115826","article-title":"Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors","volume":"90","author":"Takahashi","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0740","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1089\/ars.2007.1956","article-title":"F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications","volume":"10","author":"Basu","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0745","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bbagen.2011.04.016","article-title":"Isoprostanes and asthma","volume":"1810","author":"Voynow","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0755","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/sj.bjp.0703784","article-title":"Vasoconstrictor actions of isoprostanes via tyrosine kinase and Rho kinase in human and canine pulmonary vascular smooth muscles","volume":"132","author":"Janssen","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0760","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0090-6980(98)00079-3","article-title":"Indirect enhancement of neutrophil activity and adhesion to cultured human umbilical vein endothelial cells by isoprostanes (iPF2alpha-III and iPE2-III)","volume":"57","author":"Zahler","year":"1999","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.clinbiochem.2012.12.005_bb0765","first-page":"789232","article-title":"Pathogenic mechanisms and in vitro diagnosis of AERD","volume":"2012","author":"Sch\u00e4fer","year":"2012","journal-title":"J Allergy (Cairo)"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012006911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012006911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:39:30Z","timestamp":1757864370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912012006911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":151,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0009912012006911"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.12.005","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biochemical pathogenesis of aspirin exacerbated respiratory disease (AERD)","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}